ABSTRACT
The haematic concentration of 26 metals and the oxidative damage in 60 patients (20 males and 40 females) affected by Alzheimer's disease and 44 healthy individuals (33 males and 11 females) were compared. In patients, the following significant (p < or = 0.05) discrepancies were found: i) increment of Ca, Cd, Hg, Mg, Si and Sn, and decrement of Al, Co, Fe and Zn in serum; ii) higher concentrations of Cu, Li, Mn, Sn and Zr and lower of Fe, Hg, Mo in blood; iii) overproduction of oxidant species (SOS) and decrease of the anti-oxidant capacity (SAC) (p < or = 0.001, for both). Variables that, joined, better discriminated between patients and controls resulted to be Si, SOS, SAC, Co, Ca, Al in serum (94% of cases correctly classified) and Cu, Zr, Mo and Fe in blood (90% of cases properly categorized).
Subject(s)
Alzheimer Disease/blood , Metals/blood , Oxidative Stress , Aged , Aged, 80 and over , Alzheimer Disease/etiology , Biomarkers , Female , Humans , Hydrogen Peroxide/blood , Lipid Peroxides/blood , Male , Mass Spectrometry , Metals/adverse effects , Middle Aged , Oxidants/blood , Oxidation-Reduction , Silicon/blood , Specimen HandlingABSTRACT
There is a growing interest to evaluate metals in biological fluids in Alzheimer's disease (AD). There are numerous studies on this theme, but just few papers analyzed the relationship between haematic metal concentrations and the clinical features of the disease. In this study, possible associations between clinical features of AD and the variations in serum and blood concentration of some metals, as well as the serum oxidative status and the antioxidant capacity have been investigated. Sixty subjects with AD were enrolled. Some elements correlated with gender, depression and duration of the disease. However, the most significant result was the relationship between blood Ca and Fe levels and the severity of cognitive impairment. We hypothesize that Ca and Fe might play an important role in the pathogenetic mechanisms of AD.
Subject(s)
Alzheimer Disease/blood , Metals/blood , Aged , Aged, 80 and over , Aging/metabolism , Alzheimer Disease/etiology , Alzheimer Disease/pathology , Calcium/adverse effects , Calcium/metabolism , Female , Homeostasis , Humans , Iron/adverse effects , Iron/metabolism , Male , Mass Spectrometry , Metals/adverse effects , Middle Aged , Neurofibrillary Tangles , Neuropsychological Tests , Oxidants/blood , Silicon/bloodABSTRACT
There is growing interest in the characterization of peripheral blood lymphocytes (PBL) as a biological tool with which to investigate changes in the neurotransmitter-receptor system in neurodegenerative disorders. Here we show a slight decrease in acetylcholinesterase (AChE) and a significant increase in dopamine beta-hydroxylase (DBH) immunoreactivity in the PBL of patients with probable Alzheimer's disease (AD). Therapy with AChE inhibitors completely reversed the increase in DBH immunoreactivity. We hypothesize that the increase in DBH immunoreactivity may represent a compensatory response to cholinergic impairment. Our findings suggest that neurochemical interactions between the noradrenergic and cholinergic systems may be measured at a peripheral level in AD.
